Movement Alert|WUXI APPTEC Intraday Rise 3.15% in Regular Trading, Delisting From US 1260H List Supports Risk-Relief Repricing

Market Focus11-12

On November 12, WUXI APPTEC posted an Intraday Rise of 3.15% in Regular Trading, trading at HK$202.4 with turnover of HK$543 million.

The move followed continued positive sell-side reactions after the company was removed from the US Department of Defense 1260H list, with major institutions maintaining positive ratings and framing the development as a partial easing of geopolitical risk.

Recent coverage indicated the delisting was made after the Pentagon decided to comply with a court order tied to a preliminary injunction. JPMorgan maintained an Overweight rating with a HK$233 target price, while Goldman kept a Buy rating and HK$251 target. Earlier reports also noted strong operating momentum, including first-nine-month revenue of RMB45.54 billion, continuing operations growth of 46.3%, and backlog of RMB76.74 billion. Even so, market commentary said investors are still watching follow-on regulatory variables, including BIOSECURE-related frameworks and other US lists, meaning the latest rebound reflects risk relief rather than a full removal of cross-border policy uncertainty.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment